Loading stock data…
Agilent Technologies (A)
$136.01+0.50 (+0.37%)
Market ClosedLast close Jun 26
Agilent Technologies, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Agilent Technologies, Inc. in the Healthcare sector is trading at $133.12 with a market capitalization of $36.8B. Wall Street consensus targets $160.33 (18 analysts), implying a +20.4% move over the next 12 months. The stock is currently 17% below its 52-week high of $160.27, remaining 2.2% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $1.83B↑ | $1.80B↓ | $1.86B↑ | $1.74B↑ | $1.67B |
| Gross Profit | $990.00M↑ | $946.00M↓ | $990.00M↑ | $888.00M↑ | $866.00M |
| Operating Income | $399.00M↑ | $353.00M↓ | $443.00M↑ | $360.00M↑ | $300.00M |
| Net Income | $339.00M↑ | $305.00M↓ | $434.00M↑ | $336.00M↑ | $215.00M |
Peer Comparison
JNJUNHPFE
Fundamentals
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and App...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$36.76B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.75%
ROE
Elite ROE. Management converts capital into profit efficiently.
15.56%
Volume
Today's trading volume
1.58M
Recent News
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Agilent finalizes Biocare Medical takeover
The acquisition strengthens Agilent’s presence in areas including cancer and infectious disease diagnostic and research markets.
Agilent (A) Stock Trades Up, Here Is Why
Shares of life sciences tools company Agilent Technologies (NYSE:A) jumped 3.9% in the morning session after it announced the completion of its acquisition of Biocare Medical, a deal the company expects to boost revenue growth and margins.
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
We recently compiled a list of the 10 Best Healthcare Stocks to Buy According to Wall Street Analysts. Agilent Technologies, Inc. (NYSE:A) is among the best healthcare stocks. TheFly reported on June 11 that Piper Sandler began coverage of A with a Neutral rating and established a $150.00 price target. The firm initiated coverage of the […]
Is the Options Market Predicting a Spike in Agilent Technologies Stock?
Investors need to pay close attention to A stock based on the movements in the options market lately.